Resistance to HER2-targeted anti-cancer drugs is associated with immune evasion in cancer cells and their derived extracellular vesiclesVanesa G. Martínez, Lorraine O’Driscoll|OncoImmunology|2017Cited by 136
Neuromedin U alters bioenergetics and expands the cancer stem cell phenotype in HER2‐positive breast cancerVanesa G. Martínez, Lorraine O’Driscoll|International Journal of Cancer|2017Cited by 38